edoc

Items where Author is "Guglielmetti, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2015 | 2013 | 2004 | 2003 | 2001
Number of items: 10.

2015

Drozdov, D. and Schwarz, S. and Kutz, A. and Grolimund, E. and Rast, A. C. and Steiner, D. and Regez, K. and Schild, U. and Guglielmetti, M. and Conca, A. and Reutlinger, B. and Ottiger, C. and Buchkremer, F. and Haubitz, S. and Blum, C. and Huber, A. and Buergi, U. and Schuetz, P. and Bock, A. and Fux, C. A. and Mueller, B. and Albrich, W. C.. (2015) Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial. BMC Medicine, 13. p. 104.

2013

Drozdov, D. and Thomer, A. and Meili, M. and Schwarz, S. and Kouegbe, R. B. and Regez, K. and Guglielmetti, M. and Schild, U. and Conca, A. and Schafer, P. and Reutlinger, B. and Ottiger, C. and Buchkremer, F. and Litke, A. and Schuetz, P. and Huber, A. and Burgi, U. and Fux, C. A. and Bock, A. and Muller, B. and Albrich, W. C. and Triple, P. study group. (2013) Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections - 'triple p in uti': study protocol for a randomized controlled trial. Trials, 14. p. 84.

Litke, A. and Bossart, R. and Regez, K. and Schild, U. and Guglielmetti, M. and Conca, A. and Schafer, P. and Reutlinger, B. and Mueller, B. and Albrich, W. C.. (2013) The potential impact of biomarker-guided triage decisions for patients with urinary tract infections. Infection, 41 (4). pp. 799-809.

2004

Christ-Crain, M. and Meier, C. and Guglielmetti, M. and Huber, P. and Staub, J. J. and Muller, B.. (2004) Effect of L-Thyroxine Replacement Therapy on Skeletal and Cardiac Function in Subclinical Hypothyroidism: A Randomized Double-Blind, Placebo-Controlled Trial. Endocrinologist, 14 (3). pp. 161-166.

Meier, C. and Muller, B. and Guglielmetti, M. and Christ-Crain, M. and Staub, J. J. and Kraenzlin, M.. (2004) Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporosis International, 15 (3). pp. 209-216.

2003

Christ-Crain, M. and Meier, C. and Guglielmetti, M. and Huber, P. R. and Riesen, W. and Staub, J. J. and Muller, B.. (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis, 166 (2). pp. 379-386.

Meier, C. and Christ-Crain, M. and Guglielmetti, M. and Huber, P. and Staub, J. J. and Muller, B.. (2003) Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy. Thyroid, 13 (10). pp. 979-985.

Meier, C. and Trittibach, P. and Guglielmetti, M. and Staub, J. J. and Muller, B.. (2003) Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey. BMJ, 326 (7384). pp. 311-312.

2001

Muller, B. and Tsakiris, D. A. and Roth, C. B. and Guglielmetti, M. and Staub, J. J. and Marbet, G. A.. (2001) Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation, 31 (2). pp. 131-137.

Meier, C. and Staub, J. J. and Roth, C. B. and Guglielmetti, M. and Kunz, M. and Miserez, A. R. and Drewe, J. and Huber, P. and Herzog, R. and Muller, B.. (2001) TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). Journal of Clinical Endocrinology and Metabolism, 86 (10). pp. 4860-4866.

This list was generated on Thu Apr 25 14:58:27 2024 CEST.